Jean boulle group us$250 million+ abbott laboratories acquisition of tendyne holdings mitral valve company confirms the group’s pedigree for making serial major discoveries from mines to medical technology
Tendyne has developed a heart valve specifically designed to address the complex mitral anatomy of functional, degenerative and mixed etiology mitral regurgitation – a disorder in which the mitral valve on the left side of the heart does not close properly. Left untreated, mitral regurgitation can lead to heart failure and death. Many millions of people, in the United States alone, will benefit from mitral valve replacement.
